Tag: Tagrisso
AstraZeneca: FDA approves Tagrisso against lung cancer – 02/19/2024 at 11:06
(AOF) – AstraZeneca announces that its product Tagrisso (osimertinib) combined with chemotherapy has been approved in the United States for the treatment of adult patients with locally advanced or metastatic…
AstraZeneca: Encouraging results for Tagrisso
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
AstraZeneca: encouraging results for Tagrisso
(CercleFinance.com) – AstraZeneca announced that results from a phase III trial showed that Tagrisso (osimertinib) combined with chemotherapy demonstrated a 42% improvement in central nervous system progression-free survival (PFS) (…
AstraZeneca: Encouraging results for Tagrisso
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…